Emerald Health Therapeutics, Inc. (EMHTF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.04. It has a SharesGrow Score of 28/100, indicating a weak investment profile with 0 out of 7 criteria passed.
Financials: revenue is $10M, +294.4%/yr average growth. Net income is $40M (loss), growing at -63.9%/yr. Net profit margin is -411.9% (negative). Gross margin is -66.7% (+92.4 pp trend).
Balance sheet: total debt is $4M against $34M equity (Debt-to-Equity (D/E) ratio 0.11, conservative). Current ratio is 3.08 (strong liquidity). Debt-to-assets is 9%. Total assets: $41M.
Analyst outlook: 0 / 1 analysts rate EMHTF as buy (0%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 15/100 (Fail), Future 20/100 (Fail), Income 10/100 (Fail).
